Posts tagged patient advocates.
Blogs
4 minute read
On August 31, 2016, FDA issued a notification of public hearing and request for comments on manufacturer communications regarding unapproved uses of approved or cleared medical products. The hearing will be held on November 9-10, 2016, and individuals wishing to present information at the hearing must register by October 19, 2016. The deadline for written comments is January 9, 2017.
In the notice, FDA posed a series of questions on which it is seeking input from a broad group of stakeholders, including manufacturers, health care providers, patient advocates, payors, academics ...
Blog Editors
Recent Updates
- What Health Care Lawyers and Professionals Need to Know About Emerging Employee Benefit Issues
- A Final Rule Bites the Dust, Part II: FDA Gives up on Regulating LDTs as Medical Devices
- Oregon SB 951, Regulating the Corporate Practice of Medicine, Awaits Governor’s Signature
- DOJ Civil Rights Fraud Initiative: FCA Enforcement Expanding Into Alleged Discrimination
- Utah Law Aims to Regulate AI Mental Health Chatbots